The Influenza Centre

Activities

The Influenza Centre specializes in the detailed evaluation of human immune responses in cohort studies, as well as in human vaccination studies and clinical trials. The Centre’s vision is to reduce the global burden of influenza and other respiratory viruses by being an international leader in the development of new and improved vaccines, and by advancing the understanding of complications and immune responses following infection.

This goal will be achieved through our core activities:

• Evaluation of new vaccine formulations, including novel adjuvants (vaccine enhancers);
• Preclinical research and development of promising vaccine candidates;
• Human clinical studies of new phase I–IV influenza vaccines conducted according to Good Clinical Practice (GCP);
• Cohort studies of infected cases to understand household attack rates, long-term complications, and immune responses following infection and vaccination.

Funding

The Centre is funded by the University of Bergen, Haukeland University Hospital, the Ministry of Health and Care Services and external grant funding